These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2530459)

  • 21. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains.
    Armstrong RA; Cairns NJ; Myers D; Smith CU; Lantos PL; Rossor MN
    Neurodegeneration; 1996 Mar; 5(1):35-41. PubMed ID: 8731380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-protein deposition: a pathogenetic link between Alzheimer's disease and cerebral amyloid angiopathies.
    Coria F; Prelli F; Castaño EM; Larrondo-Lillo M; Fernandez-Gonzalez J; van Duinen SG; Bots GT; Luyendijk W; Shelanski ML; Frangione B
    Brain Res; 1988 Oct; 463(1):187-91. PubMed ID: 3058268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease.
    Selkoe DJ
    Neurobiol Aging; 1989; 10(5):387-95. PubMed ID: 2510035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abundance of the longer A beta 42 in neocortical and cerebrovascular amyloid beta deposits in Swedish familial Alzheimer's disease and Down's syndrome.
    Kalaria RN; Cohen DL; Greenberg BD; Savage MJ; Bogdanovic NE; Winblad B; Lannfelt L; Adem A
    Neuroreport; 1996 May; 7(8):1377-81. PubMed ID: 8856679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The blood-brain barrier in Alzheimer's disease.
    Vinters HV; Pardridge WM
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):446-8. PubMed ID: 2947668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in beta-amyloid (beta/A4) deposition in human patients with Down's syndrome and sporadic Alzheimer's disease.
    Armstrong RA
    Neurosci Lett; 1994 Mar; 169(1-2):133-6. PubMed ID: 8047269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcification of the basal ganglia in Down's syndrome and Alzheimer's disease.
    Mann DM
    Acta Neuropathol; 1988; 76(6):595-8. PubMed ID: 2974228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Heinrich G
    N Engl J Med; 1989 Oct; 321(17):1197. PubMed ID: 2571933
    [No Abstract]   [Full Text] [Related]  

  • 31. Lectin histochemistry of cerebral microvessels in ageing, Alzheimer's disease and Down's syndrome.
    Mann DM; Purkiss MS; Bonshek RE; Jones D; Brown AM; Stoddart RW
    Neurobiol Aging; 1992; 13(1):137-43. PubMed ID: 1531863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
    Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
    Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions.
    Wisniewski T; Lalowski M; Baumann M; Rauvala H; Raulo E; Nolo R; Frangione B
    Neuroreport; 1996 Jan; 7(2):667-71. PubMed ID: 8730853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease in Down's syndrome. A review.
    Karlinsky H
    J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.
    Glenner GG; Wong CW; Quaranta V; Eanes ED
    Appl Pathol; 1984; 2(6):357-69. PubMed ID: 6242724
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease and Down's syndrome.
    Price DL; Whitehouse PJ; Struble RG; Coyle JT; Clark AW; Delong MR; Cork LC; Hedreen JC
    Ann N Y Acad Sci; 1982; 396():145-64. PubMed ID: 6217772
    [No Abstract]   [Full Text] [Related]  

  • 37. Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses.
    Guiroy DC; Yanagihara R; Gajdusek DC
    Acta Neuropathol; 1991; 82(2):87-92. PubMed ID: 1833944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
    Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
    Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.